CMS “Actively” Pursuing Discussions On Oncology Demo Extension
The Centers for Medicare & Medicaid Services will base a decision on whether to extend the Medicare "quality of care" oncology demonstration project into 2006 on input from providers, patient groups and other stakeholders
You may also be interested in...
Medicare will reimburse Amgen's Epogen (epoetin alfa) at the average sales price plus 6% in freestanding and hospital-based dialysis facilities in 2006 under the proposed FDL-1Physician Fee Schedule for 2006, announced Aug. 1
The House Energy & Commerce Committee recommended that the Centers for Medicare & Medicaid Services extend the oncology "quality of care" demonstration project for another year
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011